Moody Lynn & Lieberson’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.5M | Sell |
6,299
-1,088
| -15% | -$475K | 0.13% | 75 |
|
|
2026
Q1 | $3.41M | Sell |
7,387
-6
| -0.1% | -$3.04K | 0.19% | 63 |
|
|
2025
Q4 | $4.19M | Sell |
7,393
-61
| -0.8% | -$32.5K | 0.22% | 63 |
|
|
2025
Q3 | $3.33M | Sell |
7,454
-16
| -0.2% | -$7.68K | 0.18% | 71 |
|
|
2025
Q2 | $4.06M | Sell |
7,470
-7,376
| -50% | -$3.86M | 0.23% | 67 |
|
|
2025
Q1 | $7.35M | Buy |
14,846
+98
| +0.7% | +$54.2K | 0.47% | 43 |
|
|
2024
Q4 | $7.7M | Sell |
14,748
-238
| -2% | -$124K | 0.47% | 42 |
|
|
2024
Q3 | $7.36M | Sell |
14,986
-231
| -2% | -$108K | 0.45% | 46 |
|
|
2024
Q2 | $6.77M | Buy |
15,217
+33
| +0.2% | +$13.1K | 0.44% | 46 |
|
|
2024
Q1 | $6.06M | Buy |
15,184
+8,457
| +126% | +$3.2M | 0.41% | 46 |
|
|
2023
Q4 | $2.27M | Sell |
6,727
-3,265
| -33% | -$973K | 0.17% | 83 |
|
|
2023
Q3 | $2.92M | Sell |
9,992
-7,301
| -42% | -$2.28M | 0.25% | 68 |
|
|
2023
Q2 | $5.91M | Buy |
17,293
+9,774
| +130% | +$2.96M | 0.48% | 49 |
|
|
2023
Q1 | $1.92M | Sell |
7,519
-275
| -4% | -$67.7K | 0.17% | 85 |
|
|
2022
Q4 | $2.07M | Hold |
7,794
| – | – | 0.19% | 83 |
|
|
2022
Q3 | $1.46M | Sell |
7,794
-4,798
| -38% | -$1.03M | 0.14% | 89 |
|
|
2022
Q2 | $2.53M | Sell |
12,592
-4,002
| -24% | -$939K | 0.23% | 76 |
|
|
2022
Q1 | $5.01M | Sell |
16,594
-13,206
| -44% | -$3.86M | 0.37% | 59 |
|
|
2021
Q4 | $10.7M | Sell |
29,800
-59,579
| -67% | -$20.5M | 0.72% | 42 |
|
|
2021
Q3 | $9.87M | Buy |
89,379
+61,227
| +217% | +$20.6M | 0.74% | 40 |
|
|
2021
Q2 | $8.63M | Buy |
28,152
+11,871
| +73% | +$3.33M | 0.65% | 46 |
|
|
2021
Q1 | $4.01M | Sell |
16,281
-25,128
| -61% | -$6.32M | 0.33% | 67 |
|
|
2020
Q4 | $11.3M | Sell |
41,409
-270
| -0.6% | -$67K | 0.97% | 35 |
|
|
2020
Q3 | $9.86M | Buy |
41,679
+8,769
| +27% | +$1.97M | 0.98% | 33 |
|
|
2020
Q2 | $6.25M | Buy |
32,910
+15,822
| +93% | +$2.84M | 0.68% | 41 |
|
|
2020
Q1 | $2.82K | Sell |
17,088
-1,563
| -8% | -$286K | 0.39% | 52 |
|
|
2019
Q4 | $3.67M | Buy |
18,651
+54
| +0.3% | +$10.1K | 0.35% | 72 |
|
|
2019
Q3 | $3.35M | Sell |
18,597
-21,252
| -53% | -$3.68M | 0.37% | 65 |
|
|
2019
Q2 | $6.97M | Sell |
39,849
-13,326
| -25% | -$2.28M | 0.77% | 46 |
|
|
2019
Q1 | $10.1M | Buy |
53,175
+744
| +1% | +$132K | 1.16% | 31 |
|
|
2018
Q4 | $8.37M | Buy |
52,431
+18,570
| +55% | +$3.15M | 1.13% | 30 |
|
|
2018
Q3 | $6.48M | Sell |
33,861
-5,415
| -14% | -$962K | 0.69% | 46 |
|
|
2018
Q2 | $6.26M | Buy |
39,276
+10,233
| +35% | +$1.56M | 0.74% | 43 |
|
|
2018
Q1 | $4M | Sell |
29,043
-3,048
| -9% | -$425K | 0.48% | 55 |
|
|
2017
Q4 | $4.58M | Buy |
+32,091
| New | +$4.02M | 0.49% | 54 |
|
|
2016
Q3 | – | Sell |
-21,879
| Closed | -$1.61M | – | 176 |
|
|
2016
Q2 | $1.61M | Buy |
+21,879
| New | +$1.54M | 0.29% | 64 |
|
Other funds holding ISRG
RG
HAM
CAM
ATO
SP
Moody Lynn & Lieberson's ISRG Position: Q2 2026 in Review
Moody Lynn & Lieberson reduced its Intuitive Surgical (ISRG) stake by 15% in Q2 2026, selling an estimated $475K and leaving 6,299 shares worth $2.5M. The position accounts for 0.13% of the portfolio, ranked #75.
Moody Lynn & Lieberson first reported a position in ISRG in Q2 2016 and has held it in 36 quarters since. The position peaked at $11.3M in Q4 2020. 636 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Moody Lynn & Lieberson held 6,299 shares of Intuitive Surgical worth $2.5M as of Q2 2026.
- Moody Lynn & Lieberson sold 1,088 Intuitive Surgical shares in Q2 2026, an estimated $475K.
- Intuitive Surgical made up 0.13% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #75 holding.
- Moody Lynn & Lieberson first reported a position in Intuitive Surgical in Q2 2016 and has held it in 36 quarters since.
- Moody Lynn & Lieberson's Intuitive Surgical position peaked at $11.3M in Q4 2020.
- 636 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.